Latterly, Pan et al. first demonstrated that NS398, a NSAID, would inhibit lung cancer cell invasion, and the mechanism was NS398 demethylating the secreted protein acidic and rich in cysteine (SPARC) gene in lung cancer [175]. The gene discussed is SPARC; the disease is lung carcinoma.